0.82
—
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About MedSci Healthcare Holdings
Its shares trade on HKEX under the ticker 2415.HK. It has been listed since 27 April 2023. In the fiscal year to 31 December 2025, it reported revenue of CN¥270.4m and net income of CN¥17.9m. At that date it held total assets of CN¥1.39bn and shareholders' equity of CN¥1.18bn.
MedSci Healthcare Holdings Ltd. operates an online professional physician platform in China. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2023-04-27. The firm mainly provides omni-channel marketing solutions, physician platform solutions, real world study solutions, clinical research auxiliary services, digital therapeutic solutions, virtual reality diagnosis, prognosis modeling services and chronic disease management services. The firm mainly operates its businesses in the domestic and overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Technology
- Listed since
- 27 Apr 2023
- Website
- ir.medsci.cn ↗
Leadership
Pay as last reported
- Dr. Fabao ZhangExecutive Chairman of the Board, since 2021CN¥1.0m
- Dr. Xinmei LiCo-Chief Executive Officer, Executive Director, since 2021CN¥551,000
- Mr. Shuai WangCo-Chief Executive Officer, Executive Director, since 2021CN¥1.2m
- Mr. Liang ChengChief Operating Officer, Executive Director, since 2024
- Mr. Chun YangVice President, Joint Company Secretary, since 2021
- Ms. Mingai HuangVice President - Medicine
- Mr. Tianpei WangVice President - Research & Development
- Mr. Xiaohui YuanFinance Controller
- Ms. Xin WangExecutive Director, since 2024
- Ms. Sau In KwanJoint Company Secretary
- Mr. Shengfeng YanNon-Executive Director
- Mr. Yiu Kwan LauIndependent Non-Executive Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- MedSci Healthcare Holdings Ltd. provides omni-channel marketing solutions in China's Health Care sector.
- The company operates a physician platform with digital therapeutic solutions for chronic disease management.
- MedSci's real world study solutions support clinical research in domestic and overseas markets.
Weaknesses
- The company's domestic market focus may limit growth opportunities in international segments.
- MedSci's reliance on physician platform solutions could increase competition risks.
- The firm's 2023 IPO may require significant capital for expansion.
Opportunities
- Expanding digital therapeutic solutions in the growing Health Care sector offers new revenue streams.
- Increasing demand for virtual reality diagnosis services in China's Health Care market presents growth potential.
- The firm can leverage omni-channel marketing solutions to enter new geographic segments.
Threats
- Rising competition in China's Health Care sector could impact market share.
- Regulatory changes in China's Health Care industry may affect operations.
- Economic downturns in China could reduce demand for digital health services.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.